• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CSSi LifeSciences, the Prince William Science Accelerator partner

CSSi LifeSciences, the Prince William Science Accelerator partner

April 7, 2017
CenterWatch Staff

CSSi LifeSciences, a partner from discovery to commercialization for biologics and vaccines, is partnering with the Prince William Science Accelerator, a public-private, commercially available wet lab space in Northern Virginia. The partnership promotes the development of new businesses and the retention and expansion of existing businesses within the county's growing and diverse life sciences community through CSSi LifeSciences' technical assistance, regulatory, clinical and commercial assessment for all Prince William Science Accelerator tenants.

The preclinical, regulatory and clinical expertise of CSSi LifeSciences combined with the Prince William Science Accelerator's innovative wet lab space will allow startup life sciences and biotechnology companies to have access to talent, multiple opportunities for collaboration and incredible prospect for expanded growth within the life sciences industry in the County. More specifically, the strategic partnership will deliver a productive environment and speed-to-market solutions to wet lab tenants through the use of unparalleled services and strategies and readily available space and equipment, as well as by providing access to industry networks, partnerships and internships.

"We are excited about partnering with the Prince William Science Accelerator and extending our reach into the Virginia market," said Jim Sergi, president, CSSi LifeSciences. "With Prince William County's already well-established and growing life sciences ecosystem, we are committed to providing the Science Accelerator with the necessary services and resources needed to help add to its growing portfolio of wet lab tenants. Together, we are the ideal solution for bringing life sciences companies' innovations to market faster and more cost-effectively."

"The Prince William Science Accelerator has strong market appeal, as there is no other space like it in the region. Partnering with CSSi LifeSciences further enhances our unique offering and pro-business support that Prince William County is recognized for," said Jeffrey A. Kaczmarek, executive director, Prince William County Department of Economic Development.

Over the years, CSSi LifeSciences has provided vital business and strategic support to "Big" biopharma, as well as incubators, and enabled the development of over 500 drugs, biologics and in vitro diagnostics. CSSi LifeSciences has a defined process that lets its clients leverage its breadth of integrated services and growth strategies to develop strategic regulatory and clinical pathways to ensure commercial success and maximize shareholder value.

First established in 2014, the Prince William Science Accelerator was designed to provide an innovative environment for entrepreneurial research and product development. Ideally situated in Innovation Park near George Mason University, the 9,000 sq. ft. facility houses nine fully built-out wet laboratory spaces suited for each tenant's specific needs. The Science Accelerator is amongst the largest and fastest-growing cluster of life and forensic sciences facilities in the region.

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing